Our Team
ActiTrexx is founded by a strong and diverse management team comprised of executives with multi-year experience (> 80 years) in different functions and fields in academia, biotechnology and pharmaceutical companies. Our team will be supported and complemented by adding experienced managers, a strong network of collaborators, advisors and key opinion leaders in the field of immunology and hematology.
Management Team
Helmut Jonuleit, CSO
Head of R&D
Treg characterization
ATMP production
Franz-Joseph Schneider, CKO
Patent applications
NBE development
Michael Kring, CFO
Controlling
Treasury duties
Economic strategy and forecasting
Advisory Board
Dr. Frank Mühlenbeck
Senior Investment Manager
LBBW Venture Capital GmbH
Ivan Morace
Senior Investment Analyst
MediVentures GmbH
Natalya Baltrukovich
Senior investment Manager
High-Tech Gründerfonds
Cornelius Sobel
Managing Director
SPC GmbH
Scientific Advisory Board
Robert Zeiser
Director of the Division of Tumor Immunology, Medical Center University of Freiburg
The scientific advisory board was established to complement the in-house expertise of ActiTrexx and comprises three members, each acclaimed experts in the field of immunology and hematology.
